Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HTD

This article was originally published in The Gray Sheet

Executive Summary

Privately held distributor of specialty medical products envisions an initial public offering after revenues increase to $250 mil., the firm states in a Dec. 14 release. With current projected sales of $115 mil., the firm has expanded its geographic coverage to the West Coast by acquiring Redmond, Washington-based specialty distributor Omnimedical. "The acquisition gives HTD a presence in 30 states with coverage of 67% of the U.S. population," the company says. HTD was formed in May 1998 through the merger of four medical specialty distributors including Triad Medical, Bimeco, Futuretech and MegaTech Medical

Latest Headlines
See All
UsernamePublicRestriction

Register

MT011099

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel